Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Humanigen Inc. (NASDAQ: HGEN) Announces Strategic Realignment To Expedite Lenzilumab Development…
IVERIC Bio Inc (NASDAQ: ISEE) Announces License Agreement With DelSiTech Ltd…
Biora Therapeutics Inc (NASDAQ: BIOR) Announces Topline Results From The Study…
Annexon Inc (NASDAQ: ANNX) Releases Encouraging Final Data Of ANX005 Study…
Exelixis Inc (NASDAQ: EXEL) Enters License Agreement With Ryvu Therapeutics S.A….
Finance
Why Your Body Needs Nitric Oxide Boost Beets For More Energy…
Top Beer Stocks for the Recession-Proof Portfolio (BUD, KEGS, SAM, TAP,…
Cutting Edge Power announces an all-new version of its popular Smart…
Lucid Group Inc (NASDAQ:LCID) Poised for Action as New Catalysts Mount
Galera Therapeutics Inc. (NASDAQ: GRTX) Announced Updated Findings Of Phase 3…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:MGNX
Tag: NASDAQ:MGNX
MacroGenics Inc. (NASDAQ: MGNX) Announces Phase 2/3 MAHOGANY and MGC018 Clinical...
Matt Wade
-
September 24, 2021
0
MacroGenics Inc. (NASDAQ:MGNX) Reports Its Q3 Financial Results and Clinical Updates...
Ward Sport
-
November 20, 2020
0
MacroGenics Inc. (NASDAQ:MGNX) Announce Publication Of Research Supporting flotetuzumab Study in...
Kate Hudson
-
June 11, 2020
0
MacroGenics Inc. (NASDAQ:MGNX) Gives Update OnBLA Review for Margetuximab In Treating...
Kate Hudson
-
June 4, 2020
0
Recent Post
Humanigen Inc. (NASDAQ: HGEN) Announces Strategic Realignment To Expedite Lenzilumab Development...
Kate Hudson
-
August 5, 2022
0
Humanigen Inc. (NASDAQ: HGEN) has announced the strategic realignment of its resources and pipeline in a bid to achieve its main clinical milestone. The...
IVERIC Bio Inc (NASDAQ: ISEE) Announces License Agreement With DelSiTech Ltd...
August 4, 2022
Biora Therapeutics Inc (NASDAQ: BIOR) Announces Topline Results From The Study...
August 3, 2022
Annexon Inc (NASDAQ: ANNX) Releases Encouraging Final Data Of ANX005 Study...
August 2, 2022
Exelixis Inc (NASDAQ: EXEL) Enters License Agreement With Ryvu Therapeutics S.A....
August 1, 2022